T1	Participants 106 129	Children's Cancer Group
T2	Participants 403 490	462 patients with disseminated disease, 49 (10.6%) had CNS disease at diagnosis (CNS+).
T3	Participants 658 746	CNS+ patients, 28 had M2 (5% to 25% blasts) or M3 (> 25% blasts) bone marrow involvement
